Literature DB >> 10953191

Perineurium contributes to axonal damage in acute inflammatory demyelinating polyneuropathy.

J Berciano1, A García, J Figols, R Muñoz, M T Berciano, M Lafarga.   

Abstract

OBJECTIVE: To assess if axonal damage in severe acute inflammatory demyelinating polyneuropathy (AIDP) correlates with the appearance of epiperineurium in nerve trunks.
BACKGROUND: Increase of endoneurial fluid pressure in nerve trunks possessing epiperineurium may be an important mechanism of axonal damage in AIDP.
METHODS: A 79-year-old man had a 2-day history of acroparesthesias and ascending paralysis culminating in quadriplegia, bilateral facial palsy, and mechanical ventilation. Five intravenous immunoglobulin cycles were given without response. He died on day 60. Electrophysiologic studies (days 4, 17, and 50) initially showed normal nerve conduction velocities with further slowing, progressive attenuation of compound muscle action potentials, and profuse denervation. The authors studied the preforaminal anterior and posterior L3 and L5 spinal roots, third and fifth lumbar nerves and their branches, and femoral and sural nerves.
RESULTS: Density of myelinated fibers was preserved in L5 ventral and dorsal roots and reduced in sural nerve. Mild de-remyelination was observed in lumbar roots. In both lumbar nerves and their branches, there were extensive de-remyelination and centrofascicular or wedge-shaped areas with marked loss of large myelinated fibers. Axonal degeneration was the predominant lesion in sural nerve.
CONCLUSION: The presence of epiperineurium correlates with a drastic change of pathology with superimposed ischemic lesions and distally accentuated axonal loss, suggesting that endoneurial fluid pressure increase could cause axonal damage in AIDP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10953191     DOI: 10.1212/wnl.55.4.552

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Thickening and contrast enhancement of spinal roots on MR imaging in Guillain-Barre syndrome: thoughts on pathologic background.

Authors:  J Berciano
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-08       Impact factor: 3.825

2.  Early identification of 'acute-onset' chronic inflammatory demyelinating polyneuropathy.

Authors:  Jia-Ying Sung; Jowy Tani; Susanna B Park; Matthew C Kiernan; Cindy Shin-Yi Lin
Journal:  Brain       Date:  2014-06-19       Impact factor: 13.501

Review 3.  Pharmacological treatment for pain in Guillain-Barré syndrome.

Authors:  Jia Liu; Lu-Ning Wang; Ewan D McNicol
Journal:  Cochrane Database Syst Rev       Date:  2015-04-09

Review 4.  Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.

Authors:  José Berciano; Antonio García; Elena Gallardo; Kristien Peeters; Ana L Pelayo-Negro; Silvia Álvarez-Paradelo; José Gazulla; Miriam Martínez-Tames; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

5.  Muscle MRI in severe Guillain-Barré syndrome with motor nerve inexcitability.

Authors:  María J Sedano; Ana Canga; Carmen de Pablos; José M Polo; José Berciano
Journal:  J Neurol       Date:  2013-01-31       Impact factor: 4.849

Review 6.  Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification.

Authors:  José Berciano; María J Sedano; Ana L Pelayo-Negro; Antonio García; Pedro Orizaola; Elena Gallardo; Miguel Lafarga; María T Berciano; Bart C Jacobs
Journal:  J Neurol       Date:  2016-06-17       Impact factor: 4.849

7.  Re-evaluating the accuracy of optimized electrodiagnostic criteria in very early Guillain-Barré syndrome: a sequential study.

Authors:  Velina Nedkova; Gerardo Gutiérrez-Gutiérrez; Francisco J Navacerrada-Barrero; José Berciano; Carlos Casasnovas
Journal:  Acta Neurol Belg       Date:  2021-02-18       Impact factor: 2.396

Review 8.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

9.  Determination of pain and response to methylprednisolone in Guillain-Barré syndrome.

Authors:  Liselotte Ruts; Rinske van Koningsveld; Bart C Jacobs; Pieter A van Doorn
Journal:  J Neurol       Date:  2007-04-11       Impact factor: 4.849

10.  Very early Guillain-Barré syndrome: A clinical-electrophysiological and ultrasonographic study.

Authors:  José Berciano; Pedro Orizaola; Elena Gallardo; Ana L Pelayo-Negro; Pascual Sánchez-Juan; Jon Infante; María J Sedano
Journal:  Clin Neurophysiol Pract       Date:  2019-11-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.